Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)

PHASE3CompletedINTERVENTIONAL
Enrollment

424

Participants

Timeline

Start Date

September 24, 2019

Primary Completion Date

June 21, 2021

Study Completion Date

May 3, 2022

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

Lebrikizumab

Subcutaneous injection

OTHER

Placebo

Subcutaneous Injection

Trial Locations (94)

2010

Holdsworth House Medical Practice, Sydney

2145

Skin & Cancer Foundation Australia, Westmead

2217

The St. George Hospital, Kogarah

3002

Sinclair Dermatology, East Melbourne

3053

Skin Health Institute Inc., Carlton

3124

Emeritus Research, Camberwell

3128

Eastern Clinical Research Unit, Box Hill

4102

Veracity Clinical Research Pty Ltd, Woolloongabba

4217

The Skin Centre, Benowa

6160

Fremantle Dermatology, Fremantle

10029

Icahn Sch of Med at Mt. Sinai, New York

10075

Sadick Research Group, New York

13500

Cabinet Médical, Martigues

15355

Korea University Ansan Hospital, Ansan-si

16499

Ajou University Hospital, Suwon

21079

CHU DIJON - Hopital le Bocage, Dijon

21431

Incheon St. Mary's Hospital, Incheon

27612

Wake Research Associates, Raleigh

28031

Hospital Infanta Leonor, Madrid

31059

Hopital Larrey, Toulouse

31903

IACT Health - VHC, Columbus

33075

CHU de Bordeaux Hopital Saint Andre, Bordeaux

33100

Alergo-Med Specjalistyczna Przychodnia Lekarska Sp Z O.O., Tarnów

33145

Community Research Foundation Inc, Miami

33765

St. Francis Medical Institute, Clearwater

40217

Skin Sciences, PLLC, Louisville

41009

Hospital Universitario Virgen Macarena, Seville

44033

Ulsan University Hospital, Ulsan

46168

The Indiana Clinical Trials Center, Plainfield

48013

Hospital De Basurto, Bilbao

48202

Henry Ford Hospital, Detroit

49085

St Joseph Dermatology and Vein Clinic, Saint Joseph

49241

Pusan National University Hospital, Pusan

50160

Kliiniliste uuringute Keskus OU, Tartu

64506

MediSearch Clinical Trials, Saint Joseph

72916

Johnson Dermatology, Fort Smith

73112

Lynn Health Science Institute, Oklahoma City

74136

Vital Prospects Clinical Research Institute, P.C., Tulsa

75475

Hopital Saint-Louis, Paris

77401

Bellaire Dermatology, Bellaire

78213

Progressive Clinical Research, San Antonio

89148

JDR Dermatology Research, Las Vegas

90045

Dermatology Research Associates, Los Angeles

90211

Wallace Medical Group, Inc., Beverly Hills

92024

California Dermatology & Clinical Research Institute, Encinitas

92119

ACRC Studies, San Diego

92708

Belle Aimee Skincare Clinic, Fountain Valley

97223

Oregon Medical Research Center, Portland

97504

Clinical Research Institute, Medford

99202

Premier Clinical Research, Spokane

06416

Central Connecticut Dermatology, Cromwell

33613-1244

ForCare Clinical Research, Tampa

02169

Beacon Clinical Research, LLC, Quincy

03801

ALLCUTIS Research, Portsmouth

02919

Clinical Partners, LLC, Johnston

06100

Burswood Dermatology, Victoria Park

T4P1K4

CARe Clinic, Red Deer

L1S7K8

CCA Medical Research, Ajax

K9A 0Z4

Skin Health, Cobourg

K2G6E2

Dermatology and Dermatologic Surgery, Ottawa

L4B 1A5

The Centre for Dermatology, Richmond Hill

LV-1001

Clinic of Dermatology and STD, Riga

LV-1003

Health Center 4, Affiliate Diagnostic Center, Riga

LV-1009

Health and Aesthetics LTD, Riga

LV-1011

Latvian Dermatology Institute, Riga

LV-3201

Smite Aija - Practice in Dermatology Venereology, Talsi

LT-44192

"JSC CD8 Alergology Clinic", Kaunas

LT-50161

Hospital of Lithuanian University of Health Sciences Kauno klinikos, Kaunas

LT-07195

Jsc Renmeda, Vilnius

LT-08109

"JSC Center for Diagnosis and Treatment of Allergic Diseases", Vilnius

LT-08406

Children's Hospital, Affiliate of Vilnius University Hospital Santaros klinikos, Vilnius

Inlita (Santaros CTC), Vilnius

LT-08441

Vilnius University Hospital Santaros klinikos, Vilnius

31-559

Diamond Clinic, Krakow

02-507

Centralny Szpital Kliniczny MSWiA, Warsaw

38-440

"Zespol Naukowo - Leczniczy Iwolang Sp. z o.o.", Iwonicz-Zdrój

40-611

Centrum Medyczne Angelius Provita, Katowice

71-434

Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin

40-851

GynCentrum Sp z o.o., Katowice

31-023

Specjalistyczny Osrodek Alergologiczno-Internistyczny ALL-ME, Krakow

20-081

Samodzielny Publiczny Szpital Kliniczny nr 1, Lublin

60-214

Centrum Alergologii Teresa Hofman, Poznan

01-142

Clinical Research Group Sp. z o.o., Warsaw

50-566

CityClinic Przychodnia Lekarsko-Psychologiczna, Wroclaw

04763

Hanyang University Medical Center, Seoul

04401

Soon Chun Hyang University Seoul Hospital, Seoul

03722

Severance Hospital, Seoul

05030

Konkuk University Medical Center, Seoul

06973

Chungang University Hospital, Seoul

07441

Hallym University Kangnam Sacred Heart Hospital, Seoul

08830

Sant Joan de Deu Serveis En Salut Mental, SANT BOI de Llobrega

03010

Hospital General Universitario Alicante, Alicante

08916

Hospital Germans Trias i Pujol, Badalona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Dermira, Inc.

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT04146363 - Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1) | Biotech Hunter | Biotech Hunter